Rhamnogalacturonan (RG) represents a major domain of pectins in plant primary cell walls, comprising branched polysaccharides with a backbone of alternating α-(1→4)-D-galacturonic acid (GalA) and α-(1→2)-L-rhamnose (Rha) residues, typically [→4)-α-D-GalpA-(1→2)-α-L-Rhap-(1→].

RG-I Domain

Rhamnogalacturonan I (RG-I) constitutes 20–35% of pectin and features a linear backbone of [→4)-α-D-GalpA-(1→2)-α-L-Rhap-(1→] disaccharides, with Rha residues often substituted at O-4 with neutral side chains like β-(1→4)-galactans, α-(1→5)-arabinans, or type I arabinogalactans.

This domain adopts a flexible helical conformation in solution, with persistence lengths around 1.4 nm, influenced by rhamnose-induced kinks that enhance solubility and gelation properties. Side chain variations during fruit ripening correlate with tissue softening, impacting cell wall mechanics.

RG-II Domain

Rhamnogalacturonan II (RG-II) forms a highly conserved, dimerizing structure based on a galacturonan backbone with four complex side chains (A–D) containing rare sugars like apiose, aceric acid, Kdo, and L-galactose, linked by over 20 glycosidic bonds.

Comprising about 10% of pectin, RG-II cross-links via borate diester bridges between apiosyl residues, rigidifying cell walls and aiding growth regulation. Subtle variations, such as methyl esterification on chain A or side chain B length, occur across organs and species, challenging prior views of absolute conservation.

Biological Roles

RG domains contribute to cell wall porosity, biomechanics, and signaling; RG-I side chains modulate firmness and enzymatic degradation, while RG-II ensures structural integrity essential for pollen tube growth and stress responses. Their prebiotic potential and immunostimulatory effects in mammals arise from gut fermentation, similar to arabinogalactans.